DCM
MACK

DAFNA Capital Management’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

DAFNA Capital Management’s Portfolio MACK Stock Details MACK Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-514,853
Closed -$2.6M – 53
2014
Q1 		$2.6M Buy
514,853
+172,400
+50% +$869K 2.23% 13
2013
Q4 		$1.83M Buy
342,453
+161,300
+89% +$860K 1.88% 12
2013
Q3 		$687K Buy
+181,153
New +$687K 0.75% 34